Combination | Patients (n=61×2) | Controls (n=571×2) | OR (95% CI) | P value | padj | ||
Positive | Negative | Positive | Negative | ||||
DRB1*16:02+DQA1*01:02+ | 17 | 54 | 105 | 1088 | 3.09 (1.65 to 5.52) | 0.00027 | 0.00108 |
DRB1*16:02+DQA1*01:02− | 1 | 1 | 121 | 1141 | 9.37 (0.11 to 733.03) | 0.18375 | 0.24501 |
DRB1*16:02−DQA1*01:02+ | 23 | 173 | 99 | 969 | 1.26 (0.76 to 2.02) | 0.31290 | 0.31291 |
DRB1*16:02−DQA1*01:02− | 81 | 914 | 41 | 128 | 0.74 (0.55 to 0.99) | 0.03878 | 0.07757 |
P values were adjusted for multiple testing with false discovery rate (FDR) step-up method.
anti-NMDAR, anti-N-methyl-D-aspartate receptor.